Sun Pharma News and Activities

Presence

Sun Pharma develops, manufactures, and sells pharmaceutical products. Its main offerings include generic medicines, specialty treatments, and active ingredients for hospitals, pharmacies, and healthcare providers in India and international markets.

Sun Pharma products and services overview:

Generic medicines
Specialty medicines
Active ingredients
Consumer healthcare
Injectable drugs
Over the counter

Revenue: ~$6 billion

Employees: 43,000

Headquarters: Mumbai, India

Sun Pharma is one of the...

Sun Pharma is a company listed under the stock ticker SUNPHARMA (IN).

Sun Pharma has a direct presence in 2 countries.

Sun Pharma has 4 subsidiaries including Chattem Chemicals, Natco Pharma and Sun Pharma USA.

They are in:

Pharmaceuticals80%
Chemicals20%

Acquisition, funding and merger involving Sun Pharma.

Sun Pharma has announced the acquisition of Organon International (posted on January 22 2026).
Sun Pharma has acquired Checkpoint Therapeutics (posted on June 2 2025).
Sun Pharma has acquired Taro Pharmaceutical (posted on June 25 2024).

Executives

View the org chart displaying its 97 main executives

Most searched biographies at Sun Pharma

Popular executive movements at Sun Pharma

Andreas Eugen Busch has joined the company as Director (posted on May 15 2026).
Sagar Mahajan has joined the company as General Manager, Business Development (posted on May 8 2026).
Rama Bijapurkar, Independent Director, will leave the company on May 20, 2026 (posted on February 3 2026).

Click here to view some more movements at Sun Pharma

Create your alert
to follow the executive moves at Sun Pharma.